114 related articles for article (PubMed ID: 37365680)
1. E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma.
Chen SN; Mai ZY; Mai JN; Liang W; Dong ZX; Ju FE; Chan SH; Fang Z; Xu Y; Uziel O; He C; Zhang XD; Zheng Y
Br J Haematol; 2023 Aug; 202(4):840-855. PubMed ID: 37365680
[TBL] [Abstract][Full Text] [Related]
2. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
3. E2F2 and CREB cooperatively regulate transcriptional activity of cell cycle genes.
Laresgoiti U; Apraiz A; Olea M; Mitxelena J; Osinalde N; Rodriguez JA; Fullaondo A; Zubiaga AM
Nucleic Acids Res; 2013 Dec; 41(22):10185-98. PubMed ID: 24038359
[TBL] [Abstract][Full Text] [Related]
4. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.
Feliciano A; Garcia-Mayea Y; Jubierre L; Mir C; Hummel M; Castellvi J; Hernández-Losa J; Paciucci R; Sansano I; Sun Y; Ramón Y Cajal S; Kondon H; Soriano A; Segura M; Lyakhovich A; LLeonart ME
Cell Death Dis; 2017 Oct; 8(10):e3141. PubMed ID: 29072692
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer.
Li X; Zhang Z; Jiang H; Li Q; Wang R; Pan H; Niu Y; Liu F; Gu H; Fan X; Gao J
Cell Physiol Biochem; 2018; 51(5):2324-2340. PubMed ID: 30537738
[TBL] [Abstract][Full Text] [Related]
6. Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.
Wang H; Zhang X; Liu Y; Ni Z; Lin Y; Duan Z; Shi Y; Wang G; Li F
Oncotarget; 2016 Jun; 7(24):36577-36589. PubMed ID: 27174918
[TBL] [Abstract][Full Text] [Related]
7. Low shear stress induces endothelial cell apoptosis and monocyte adhesion by upregulating PECAM‑1 expression.
Xie X; Wang F; Zhu L; Yang H; Pan D; Liu Y; Qu X; Gu Y; Li X; Chen S
Mol Med Rep; 2020 Jun; 21(6):2580-2588. PubMed ID: 32323830
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein.
Zhang M; Xu Y; Zhang Y; Li B; Lou G
Cell Signal; 2021 Aug; 84():110014. PubMed ID: 33894314
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
10. Decreased PECAM1-mediated TGF-β1 expression in the mid-secretory endometrium in women with recurrent implantation failure.
Guo F; Si C; Zhou M; Wang J; Zhang D; Leung PCK; Xu B; Zhang A
Hum Reprod; 2018 May; 33(5):832-843. PubMed ID: 29617817
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.
Zhou J; Zhu Y; Cheng M; Dinesh D; Thorne T; Poh KK; Liu D; Botros C; Tang YL; Reisdorph N; Kishore R; Losordo DW; Qin G
Circulation; 2009 Sep; 120(13):1213-21. PubMed ID: 19752322
[TBL] [Abstract][Full Text] [Related]
12. miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2.
Li T; Yang J; Lv X; Liu K; Gao C; Xing Y; Xi T
Biotechnol Lett; 2014 Sep; 36(9):1743-52. PubMed ID: 24793496
[TBL] [Abstract][Full Text] [Related]
13. Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion.
Bollig-Fischer A; Marchetti L; Mitrea C; Wu J; Kruger A; Manca V; Drăghici S
Bioinformatics; 2014 Nov; 30(21):3036-43. PubMed ID: 25028721
[TBL] [Abstract][Full Text] [Related]
14. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
[TBL] [Abstract][Full Text] [Related]
15. The role of E2F2 in cancer progression and its value as a therapeutic target.
Gao Y; Qiao X; Liu Z; Zhang W
Front Immunol; 2024; 15():1397303. PubMed ID: 38807594
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.
Hong SH; Eun JW; Choi SK; Shen Q; Choi WS; Han JW; Nam SW; You JS
Oncotarget; 2016 May; 7(22):32628-40. PubMed ID: 27081696
[TBL] [Abstract][Full Text] [Related]
18. LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
Cao J; Wang H; Liu G; Tang R; Ding Y; Xu P; Wang H; Miao J; Gu X; Han S
J Cell Mol Med; 2021 Jan; 25(2):1178-1189. PubMed ID: 33342041
[TBL] [Abstract][Full Text] [Related]
19. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
[TBL] [Abstract][Full Text] [Related]
20. GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.
Cultrara CN; Kozuch SD; Ramasundaram P; Heller CJ; Shah S; Beck AE; Sabatino D; Zilberberg J
BMC Cancer; 2018 Dec; 18(1):1263. PubMed ID: 30563499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
